| RESEARCH ARTICLE |
|
| Year : 2006 | Volume
: 27
| Issue : 3 | Page : 63-66 |
|
|
The Role of Amrita Bhallataka Avaleha and Virechana Karma in the Management of Amavata
Priti Sharma1, MS Baghel2
1 M.D. (Ayu) - Kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India
2 Director- I.P.G.T. & R.A., Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India
Correspondence Address:
Priti Sharma
M.D. (Ayu) - Kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar
India
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
Ayurveda has taken the foremost place in the management of crippling discase. Amavata is one of them. From the modern point of view, this disease looks similar to Rheumatoid arthritis in its clinical appearance. In the whole world rheumatic disease are commonest cause of physical impairment in society. The lives of more than one million people are physically impaired by rheumatic disorders and fifth of these are severely disabled. Due to its wide prevalence chronicity, morbidity, crippling nature and lack of effective drugs attract to look for suitable remedy of the disease Amavata. Bhallataka and Guduchi are the Rasayana drugs, so in general they improve the qualities of body element thereby curing the disease as well as maintaining the healthy state of the body. But, there were many side effects noted in previous research works on Bhallataka. So to search for better form or acceptable form of Bhallataka as well as to use combination of two Rasayana drugs, for the present study as Shamana therapy Amritabhallataka has been chosen. Which is mentioned in Bhavaprakash Madhyama Khanda 54/75-82. Virechana is mentioned in Chakradutta Chikitsa Sutra and many work with Virechana Karma on Amavata have been successfully carried out. So in this study Virechana has been conducted. Total 35 patients of Amavata were treated. These patients were randomly distributed into two treatment groups. Amritabhallataka without Virechana (14 patients) and Amrita Bhallataka with Virechana (11 patients) were taken. Out of above said group. The improvement was statistically highly significant in both the groups, but comparatively Shodhana group (group B) had better relief than Shamana group (group A) Amrita Bhallataka Avaleha was well tolerated by most of the patients (31), very minor side effects observed in few (4) patients. |
|
|
|
| [PDF Not available]* |
|
 |
|
